As of 2026-04-04, the Relative Valuation of Glenmark Pharmaceuticals Ltd (GLENMARK.NS) is 1,260.79 INR. This relative valuation is based on P/E multiples. With the latest stock price at 2,091.80 INR, the upside of Glenmark Pharmaceuticals Ltd based on Relative Valuation is -39.7%.
The range of the Relative Valuation is 1,031.88 - 1,680.17 INR.
| Range | Selected | |
| Trailing P/E multiples | 27.3x - 36.0x | 31.2x |
| Forward P/E multiples | 22.2x - 34.1x | 27.3x |
| Fair Price | 1,031.88 - 1,680.17 | 1,260.79 |
| Upside | -50.7% - -19.7% | -39.7% |
| Date | P/E |
| 2026-04-02 | 55.42 |
| 2026-04-01 | 55.52 |
| 2026-03-30 | 56.22 |
| 2026-03-27 | 57.48 |
| 2026-03-25 | 57.35 |
| 2026-03-24 | 55.59 |
| 2026-03-23 | 55.11 |
| 2026-03-20 | 57.76 |
| 2026-03-19 | 55.77 |
| 2026-03-18 | 57.84 |
| 2026-03-17 | 56.81 |
| 2026-03-16 | 57.23 |
| 2026-03-13 | 57.55 |
| 2026-03-12 | 59.88 |
| 2026-03-11 | 60.13 |
| 2026-03-10 | 59.30 |
| 2026-03-09 | 56.14 |
| 2026-03-06 | 56.35 |
| 2026-03-05 | 55.83 |
| 2026-03-04 | 53.98 |
| 2026-03-02 | 56.54 |
| 2026-02-27 | 56.81 |
| 2026-02-26 | 56.32 |
| 2026-02-25 | 55.07 |
| 2026-02-24 | 54.87 |
| 2026-02-23 | 53.87 |
| 2026-02-20 | 54.06 |
| 2026-02-19 | 53.17 |
| 2026-02-18 | 53.57 |
| 2026-02-17 | 53.89 |
| 2026-02-16 | 53.76 |
| 2026-02-13 | 52.91 |
| 2026-02-12 | 53.95 |
| 2026-02-11 | 53.40 |
| 2026-02-10 | 51.76 |
| 2026-02-09 | 52.41 |
| 2026-02-06 | 51.06 |
| 2026-02-05 | 52.19 |
| 2026-02-04 | 51.77 |
| 2026-02-03 | 51.86 |
| 2026-02-02 | 50.93 |
| 2026-02-01 | 51.30 |
| 2026-01-30 | 53.68 |
| 2026-01-29 | 52.46 |
| 2026-01-28 | 52.86 |
| 2026-01-27 | 53.18 |
| 2026-01-23 | 52.16 |
| 2026-01-22 | 53.10 |
| 2026-01-21 | 51.67 |
| 2026-01-20 | 51.16 |